(AFX UK Focus) 2005-05-18 14:38 GMT: Eli Lilly gets additional OKs for Strattera in Europe (Interactive Investor)
home > yahoo news
NEW YORK (AFX) -- Eli Lilly & Co. Wednesday said it has received additional approvals to market its Strattera drug treatment for attention deficit/hyperactivity disorder in children and adolescents in Europe.
- link to (AFX UK Focus) 2005-05-18 14:38 GMT: Eli Lilly gets additional OKs for Strattera in Europe (Interactive Investor) -
Last update: 06/01/2005